These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29668562)

  • 1. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
    Kamal F; Khan MA; Molnar MZ; Howden CW
    J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump inhibitors and chronic kidney disease: Hidden consequences of an inappropriate drug use?
    Schiffl H; Al-Nemnem E; Lang SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):312-319. PubMed ID: 32394903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proton pump inhibitors and kidney].
    Desbuissons G; Deray G; Mercadal L
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S115-S124. PubMed ID: 29274872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
    Wu B; Li D; Xu T; Luo M; He Z; Li Y
    Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between proton pump inhibitors and renal disease.
    Morschel CF; Mafra D; Eduardo JCC
    J Bras Nefrol; 2018; 40(3):301-306. PubMed ID: 30010692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
    Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
    Wyatt CM
    Kidney Int; 2016 Apr; 89(4):732-3. PubMed ID: 26994567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
    Al-Aly Z; Maddukuri G; Xie Y
    Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
    Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
    Corsonello A; Lattanzio F
    Trends Cardiovasc Med; 2019 Aug; 29(6):353-360. PubMed ID: 30389278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
    Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
    Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor therapy and potential long-term harm.
    Corleto VD; Festa S; Di Giulio E; Annibale B
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Li T; Xie Y; Al-Aly Z
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):182-187. PubMed ID: 29432214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors, adverse events and increased risk of mortality.
    Lanas-Gimeno A; Hijos G; Lanas Á
    Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
    [No Abstract]   [Full Text] [Related]  

  • 19. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
    J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.